Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

5,594 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 5,594 results

Not applicableActive Not RecruitingNCT05623787
What this trial is testing

Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal Neoplasms

Who this might be right for
Peritoneal CarcinomatosisPeritoneal MetastasesAppendix Cancer+2 more
Laval University 30
Testing effectiveness (Phase 2)Study completedNCT05586516
What this trial is testing

Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
iOnctura 16
Large-scale testing (Phase 3)Study completedNCT01121848
What this trial is testing

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Sanofi 108
Early research (Phase 1)Study completedNCT01839604
What this trial is testing

A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular Carcinoma

Who this might be right for
Advanced Adult Hepatocellular CarcinomaHepatocellular Carcinoma Metastatic
AstraZeneca 58
Testing effectiveness (Phase 2)UnknownNCT00178763
What this trial is testing

Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer

Who this might be right for
Pancreatic Neoplasms
The University of Texas Health Science Center, Houston 36
Not applicableLooking for participantsNCT05186116
What this trial is testing

LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis

Who this might be right for
Colon AdenocarcinomaLiver Metastasis Colon Cancer
Azienda Ospedaliero-Universitaria di Modena 25
Testing effectiveness (Phase 2)Looking for participantsNCT06662006
What this trial is testing

Nal-IRI/5-FU/LV Chemotherapy Combined With PD-L1 Inhibitor and Multi-target Anti-angiogenic Small Molecule±SBRT as Second-line Therapy in Metastatic Pancreatic Cancer Patients

Who this might be right for
Advanced Metastatic Pancreatic Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 56
Testing effectiveness (Phase 2)Temporarily pausedNCT03417921
What this trial is testing

ABTL0812 in Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Ability Pharmaceuticals SL 60
Not applicableActive Not RecruitingNCT03364621
What this trial is testing

Comprehensive Genomic Profiling of Colorectal Cancer Patients With Isolated Liver Metastases to Understand Response & Resistance to Cancer Therapy

Who this might be right for
Colorectal CancerColorectal Cancer MetastaticHepatic Metastases
University Health Network, Toronto 17
Large-scale testing (Phase 3)Study completedNCT00917384
What this trial is testing

Study of IMC-1121B (Ramucirumab) With Best Supportive Care in Participants With Gastric Cancer and Adenocarcinoma

Who this might be right for
Gastric CancerAdenocarcinoma
Eli Lilly and Company 355
Testing effectiveness (Phase 2)UnknownNCT05241899
What this trial is testing

A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer

Who this might be right for
Gastric Cancer
The First Affiliated Hospital of Zhengzhou University 56
Large-scale testing (Phase 3)Study completedNCT02872116
What this trial is testing

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Who this might be right for
Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma
Bristol-Myers Squibb 2,031
Not applicableStudy completedNCT01693848
What this trial is testing

"Cancersensor" Metastasis Resection

Who this might be right for
Metastatic Colorectal Cancer
Institut National de la Santé Et de la Recherche Médicale, France 10
Large-scale testing (Phase 3)Study completedNCT00212615
What this trial is testing

XELOX III. Xeloda in Combination With Eloxatin for Patients With Advanced or Metastatic Colorectal Cancer

Who this might be right for
C04.588.274.476.411.307
Odense University Hospital 116
Testing effectiveness (Phase 2)Looking for participantsNCT05286814
What this trial is testing

PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

Who this might be right for
Metastatic Colorectal Cancer (Mcrc)Intrahepatic Cholangiocarcinoma (Icc)Intrahepatic Bile Duct Cancer+10 more
National Cancer Institute (NCI) 70
Not applicableStudy completedNCT04330716
What this trial is testing

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Who this might be right for
Breast CancerOvarian CancerPancreatic Cancer+1 more
Dana-Farber Cancer Institute 269
Not applicableStudy completedNCT01834014
What this trial is testing

Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal Cancer
EPS Corporation 110
Large-scale testing (Phase 3)Study completedNCT00061815
What this trial is testing

Study of Cetuximab, Oxaliplatin, 5-FU/LV Versus Oxaliplatin, 5-FU/LV in Patients With Previously Treated Metastatic, EGFR-Positive Colorectal Cancer

Who this might be right for
Colorectal Cancer
Eli Lilly and Company 102
Testing effectiveness (Phase 2)UnknownNCT01639326
What this trial is testing

Study to Evaluate the Efficacy and Safety of FOLFIRI-AD in Patients With Metastatic Colorectal Cancer UGT1A Genotype 1

Who this might be right for
Metastatic Colorectal Cancer
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 96
Testing effectiveness (Phase 2)Study completedNCT00083785
What this trial is testing

Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases

Who this might be right for
Liver MetastasisColorectal NeoplasmsLiver Neoplasms+1 more
Light Sciences LLC 25
Next Page